Cite
HARVARD Citation
Cook, S. et al. (2022). 022 Updated safety of cladribine tablets in multiple sclerosis patients: integrated safety analysis and post-approval data. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A20. [Online].